Abstract
Glycosylation modifications have been reported in a number of disease states and, as a result, there is significant focus on the discovery and development of glycan-based biomarkers. Glyco-biomarkers have the potential to enhance the efficacy and efficiency of the diagnostic procedures for these diseases.
Original language | English |
---|---|
Pages (from-to) | 327-330 |
Number of pages | 4 |
Journal | Biochemical Society Transactions |
Volume | 39 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2011 |
Externally published | Yes |
Keywords
- Biomarker
- Cancer
- Glycosylation
- Rheumatoid arthritis
- Schizophrenia